• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
The Diagnostics Pipeline: FDA Approves First Ever Fentanyl Test Strips for OTC Use

The Diagnostics Pipeline: FDA Approves First Ever Fentanyl Test Strips for OTC Use

by Glenn S. Demby | Nov 24, 2023 | Clinical Diagnostic Insider, FDA-dtet

Approval for OTC use of a urine drug test that can be performed by non-CLIA facilities could help expand accessibility, expert says.

This content is for Paid Members only.
Login Register
November 2023 Labs in Court

November 2023 Labs in Court

by Glenn S. Demby | Oct 20, 2023 | Elite, Essential, Lab Compliance Advisor, Laboratory Industry Report, Labs in Court, National Lab Reporter, Premium

This month’s roundup of cases includes Walgreens’ settlement with Theranos customers, kickbacks, and age discrimination.

This content is for Paid Members only.
Login Register
Enforcement Trends: The Urine Drug Testing Crackdown and Three Ways to Avoid It

Enforcement Trends: The Urine Drug Testing Crackdown and Three Ways to Avoid It

by Glenn S. Demby | Jul 31, 2023 | Enforcement-nir, National Lab Reporter

False billing of urine drug tests (UDTs) continues to be a focus for enforcement agencies in 2023, here’s how to avoid compliance issues.

This content is for Paid Members only.
Login Register
July 2023 Enforcement Roundup

July 2023 Enforcement Roundup

by Rachel Muenz | Jul 4, 2023 | Enforcement-lca, Lab Compliance Advisor

Though UDT-related enforcement actions predominate, an uncommon vendor-related case was in the mix this month.

This content is for Paid Members only.
Login Register
July 2023 Labs in Court

July 2023 Labs in Court

by Glenn S. Demby | Jul 4, 2023 | Lab Compliance Advisor, Labs in Court

Recent cases involve COVID-19 fraud, UDTs, and the latest HIPAA Right of Access settlement.

This content is for Paid Members only.
Login Register
« Older Entries

Log In


Join Now | Lost Password?

  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
Copyright © 2023 G2Intelligence.com